Tanvex BioPharma Revenue

In the year 2024, Tanvex BioPharma had annual revenue of 34.68M TWD, down -43.53%. Tanvex BioPharma had revenue of 2.81M in the quarter ending December 31, 2024, a decrease of -69.08%.

Revenue

34.68M

Revenue Growth

-43.53%

P/S Ratio

429.82

Revenue / Employee

n/a

Employees

n/a

Market Cap

14.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.68M	-26.73M	-43.53%
Dec 31, 2023	61.41M	39.01M	174.11%
Dec 31, 2022	22.40M	17.00M	314.43%
Dec 31, 2021	5.41M	5.11M	1,702.00%
Dec 31, 2020	300.00K	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Polaris Group	107.00M
Lumosa Therapeutics	39.15M
Pegavision	6.82B

Revenue Rankings